Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI03251444

Publication Date:

March 14, 2024

Pages:

112

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Bio Contract Development and Manufacturing Organizations (CDMOs) market size was valued at US$ 21160 million in 2023. With growing demand in downstream market, the Bio Contract Development and Manufacturing Organizations (CDMOs) is forecast to a readjusted size of US$ 42230 million by 2030 with a CAGR of 10.4% during review period.
The research report highlights the growth potential of the global Bio Contract Development and Manufacturing Organizations (CDMOs) market. Bio Contract Development and Manufacturing Organizations (CDMOs) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Bio Contract Development and Manufacturing Organizations (CDMOs). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Bio Contract Development and Manufacturing Organizations (CDMOs) market.
A contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.
Key Features:
The report on Bio Contract Development and Manufacturing Organizations (CDMOs) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Bio Contract Development and Manufacturing Organizations (CDMOs) market. It may include historical data, market segmentation by Type (e.g., API Development, Manufacturing), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Bio Contract Development and Manufacturing Organizations (CDMOs) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Bio Contract Development and Manufacturing Organizations (CDMOs) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Bio Contract Development and Manufacturing Organizations (CDMOs) industry. This include advancements in Bio Contract Development and Manufacturing Organizations (CDMOs) technology, Bio Contract Development and Manufacturing Organizations (CDMOs) new entrants, Bio Contract Development and Manufacturing Organizations (CDMOs) new investment, and other innovations that are shaping the future of Bio Contract Development and Manufacturing Organizations (CDMOs).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Bio Contract Development and Manufacturing Organizations (CDMOs) market. It includes factors influencing customer ' purchasing decisions, preferences for Bio Contract Development and Manufacturing Organizations (CDMOs) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Bio Contract Development and Manufacturing Organizations (CDMOs) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Bio Contract Development and Manufacturing Organizations (CDMOs) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Bio Contract Development and Manufacturing Organizations (CDMOs) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Bio Contract Development and Manufacturing Organizations (CDMOs) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Bio Contract Development and Manufacturing Organizations (CDMOs) market.
Market Segmentation:
Bio Contract Development and Manufacturing Organizations (CDMOs) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
API Development
Manufacturing
Drug Delivery
Segmentation by application
Pharmaceutical Company
Biotechnology Company
Generic Company
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lonza
Boehringer 鈥嶪ngelheim
Celltrion
Fujifilm
Selexis
Ology Bio
Ardena
Catalent
AGC
Amgen

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size 2019-2030
2.1.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Segment by Type
2.2.1 API Development
2.2.2 Manufacturing
2.2.3 Drug Delivery
2.3 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type
2.3.1 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Market Share by Type (2019-2024)
2.4 Bio Contract Development and Manufacturing Organizations (CDMOs) Segment by Application
2.4.1 Pharmaceutical Company
2.4.2 Biotechnology Company
2.4.3 Generic Company
2.5 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application
2.5.1 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Market Share by Application (2019-2024)
3 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Player
3.1 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Market Share by Players
3.1.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Players (2019-2024)
3.1.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Players (2019-2024)
3.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Bio Contract Development and Manufacturing Organizations (CDMOs) by Regions
4.1 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Regions (2019-2024)
4.2 Americas Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Growth (2019-2024)
4.3 APAC Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Growth (2019-2024)
4.4 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Growth (2019-2024)
4.5 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Growth (2019-2024)
5 Americas
5.1 Americas Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2019-2024)
5.2 Americas Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2019-2024)
5.3 Americas Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Region (2019-2024)
6.2 APAC Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2019-2024)
6.3 APAC Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) by Country (2019-2024)
7.2 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2019-2024)
7.3 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) by Region (2019-2024)
8.2 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2019-2024)
8.3 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Forecast by Regions (2025-2030)
10.1.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Forecast by Regions (2025-2030)
10.1.2 Americas Bio Contract Development and Manufacturing Organizations (CDMOs) Forecast
10.1.3 APAC Bio Contract Development and Manufacturing Organizations (CDMOs) Forecast
10.1.4 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Forecast
10.1.5 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Forecast
10.2 Americas Bio Contract Development and Manufacturing Organizations (CDMOs) Forecast by Country (2025-2030)
10.2.1 United States Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.2.2 Canada Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.2.3 Mexico Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.2.4 Brazil Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.3 APAC Bio Contract Development and Manufacturing Organizations (CDMOs) Forecast by Region (2025-2030)
10.3.1 China Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.3.2 Japan Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.3.3 Korea Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.3.4 Southeast Asia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.3.5 India Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.3.6 Australia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.4 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Forecast by Country (2025-2030)
10.4.1 Germany Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.4.2 France Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.4.3 UK Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.4.4 Italy Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.4.5 Russia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.5 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Forecast by Region (2025-2030)
10.5.1 Egypt Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.5.2 South Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.5.3 Israel Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.5.4 Turkey Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.5.5 GCC Countries Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast
10.6 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Forecast by Type (2025-2030)
10.7 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Bio Contract Development and Manufacturing Organizations (CDMOs) Product Offered
11.1.3 Lonza Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Boehringer 鈥嶪ngelheim
11.2.1 Boehringer 鈥嶪ngelheim Company Information
11.2.2 Boehringer 鈥嶪ngelheim Bio Contract Development and Manufacturing Organizations (CDMOs) Product Offered
11.2.3 Boehringer 鈥嶪ngelheim Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Boehringer 鈥嶪ngelheim Main Business Overview
11.2.5 Boehringer 鈥嶪ngelheim Latest Developments
11.3 Celltrion
11.3.1 Celltrion Company Information
11.3.2 Celltrion Bio Contract Development and Manufacturing Organizations (CDMOs) Product Offered
11.3.3 Celltrion Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Celltrion Main Business Overview
11.3.5 Celltrion Latest Developments
11.4 Fujifilm
11.4.1 Fujifilm Company Information
11.4.2 Fujifilm Bio Contract Development and Manufacturing Organizations (CDMOs) Product Offered
11.4.3 Fujifilm Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Fujifilm Main Business Overview
11.4.5 Fujifilm Latest Developments
11.5 Selexis
11.5.1 Selexis Company Information
11.5.2 Selexis Bio Contract Development and Manufacturing Organizations (CDMOs) Product Offered
11.5.3 Selexis Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Selexis Main Business Overview
11.5.5 Selexis Latest Developments
11.6 Ology Bio
11.6.1 Ology Bio Company Information
11.6.2 Ology Bio Bio Contract Development and Manufacturing Organizations (CDMOs) Product Offered
11.6.3 Ology Bio Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Ology Bio Main Business Overview
11.6.5 Ology Bio Latest Developments
11.7 Ardena
11.7.1 Ardena Company Information
11.7.2 Ardena Bio Contract Development and Manufacturing Organizations (CDMOs) Product Offered
11.7.3 Ardena Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Ardena Main Business Overview
11.7.5 Ardena Latest Developments
11.8 Catalent
11.8.1 Catalent Company Information
11.8.2 Catalent Bio Contract Development and Manufacturing Organizations (CDMOs) Product Offered
11.8.3 Catalent Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Catalent Main Business Overview
11.8.5 Catalent Latest Developments
11.9 AGC
11.9.1 AGC Company Information
11.9.2 AGC Bio Contract Development and Manufacturing Organizations (CDMOs) Product Offered
11.9.3 AGC Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 AGC Main Business Overview
11.9.5 AGC Latest Developments
11.10 Amgen
11.10.1 Amgen Company Information
11.10.2 Amgen Bio Contract Development and Manufacturing Organizations (CDMOs) Product Offered
11.10.3 Amgen Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Amgen Main Business Overview
11.10.5 Amgen Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂